Loading...
Loading...
Oppenheimer maintained its Ceragon Networks
CRNT Outperform rating and $12 price target in a research report published today.
In the report, Oppenheimer stated, "VIT reported better than expected 4Q11 revenue of $87.2M, but EPS of $0.20 slightly missed our projection due to weaker than expected margins that declined Y/Y and Q/Q. For 2012, VIT guided revenue to grow at least 27.1% Y/Y to $360M and EPS to $0.86-$0.92."
Shares of Ceragon Networks closed today at $9.11, down 2.15% from Monday's market close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in